METHOD OF PRODUCING A CELLULAR MODEL FOR SARS-COV-2 VIRUS ANALYSIS Russian patent published in 2020 - IPC C12N5/00 

Abstract RU 2730250 C2

FIELD: biotechnology.

SUBSTANCE: invention represents a method involving culturing Caco2 cells on a semipermeable membrane insert in conditions of continuous current of the culture medium in a closed cycle for 7 days at the following parameters: pressure in the circuit from minus 12±25 % kPa to 12±25 % kPa, frequency of change of pressure from 4 to 5 Hz, difference of flow rate of culture medium from 0 to 0.9 mcl/s, average rate of culture medium current 5 mcl/min.

EFFECT: invention enables to obtain a differentiated monolayer of Caco2 cells with a physiological ratio of the expression of ACE2 and TMPRSS2 genes and can be used to produce a cell model based on differentiated human colon epithelial cells line Caco2 for studying SARS-CoV-2 virus.

1 cl, 2 ex

Similar patents RU2730250C2

Title Year Author Number
METHOD FOR NON-INVASIVE SEMI-QUANTITATIVE ASSESSMENT OF VIABILITY OF MDA-MB-231 CELLS IN MULTIORGAN MICROPHYSIOLOGICAL MODELS 2020
  • Shkurnikov Maksim Iurevich
  • Poloznikov Andrei Aleksandrovich
RU2752426C2
RECOMBINANT INFLUENZA VIRUS INTENDED FOR THE PREVENTION OF COVID-19 AND INFLUENZA, METHOD OF ITS PRODUCTION AND USE 2022
  • Sergeeva Mariya Valerevna
  • Elshin Nikita Dmitrievich
  • Romanovskaya-Romanko Ekaterina Andreevna
  • Stukova Marina Anatolevna
  • Lioznov Dmitrij Anatolevich
RU2802058C1
TREATMENT AND/OR PREVENTION OF DISEASE OR SYNDROME ASSOCIATED WITH VIRAL INFECTION 2021
  • Zhukovsky Nikolay
RU2823437C2
INTEGRATIVE PLASMID VECTOR PVEAL2-S-RBD, PROVIDING THE EXPRESSION AND SECRETION OF THE RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF THE SARS-COV-2 CORONAVIRUS IN MAMMALIAN CELLS, THE RECOMBINANT CHO-K1-RBD CELL LINE STRAIN AND THE RECOMBINANT SARS-COV-2 RBD PROTEIN PRODUCED BY THE SPECIFIED STRAIN OF THE CELL LINE CHO-K1-RBD 2021
  • Merkuleva Yuliya Aleksandrovna
  • Shcherbakov Dmitrij Nikolaevich
  • Belenkaya Svetlana Valerevna
  • Isaeva Anastasiya Aleksandrovna
  • Nesmeyanova Valentina Sergeevna
  • Shanshin Daniil Vasilevich
  • Volkova Natalya Vyacheslavovna
  • Ilichev Aleksandr Alekseevich
  • Karpenko Larisa Ivanovna
RU2752858C1
DNA VACCINE AGAINST SARS-COV-2 VIRUS BASED ON GENE THERAPY DNA VECTOR GDTT1.8NAS12, METHOD FOR ITS PREPARATION, STRAINS CARRYING GENE-THERAPY DNA VECTORS, METHOD FOR THEIR PREPARATION, METHOD FOR PRODUCTION ON INDUSTRIAL SCALE OF GENE-THERAPY DNA VECTORS 2020
  • Gamolski Anton
RU2759227C2
METHOD FOR ASSESSING CYTOTOXICITY OF RIBOSOME-INACTIVATING PROTEINS OF TYPE II IN VITRO 2015
  • Krajnova Natalja Aleksandrovna
  • Maltseva Diana Vasilevna
  • Kondrashina Olga Vladimirovna
  • Khaustova Nadezhda Aleksandrovna
  • Tonevitskij Aleksandr Grigorevich
RU2580225C1
METHOD FOR DETERMINING THE ACTIVITY OF NEUTRALISING ANTIBODIES AGAINST SARS-CoV-2 IN THE SERUM OR PLASMA OF PEOPLE WITH PAST CASES OF COVID-19 OR VACCINATED WITH PREVENTIVE VACCINES AGAINST THE NOVEL CORONAVIRUS INFECTION COVID-19 USING A SET OF ENZYME IMMUNOASSAY REAGENTS CONTAINING A RECOMBINANT RECEPTOR-BINDING DOMAIN (RBD) OF SURFACE GLYCOPROTEIN S OF CORONAVIRUS SARS-CoV-2 AND RECOMBINANT HUMAN RECEPTOR ACE2 2021
  • Kostin Nikita Nikolaevich
  • Bobik Tatyana Vladimirovna
  • Skryabin Georgij Andreevich
  • Simonova Mariya Aleksandrovna
  • Balmasova Irina Petrovna
  • Abrikosova Viktoriya Aleksandrovna
  • Mokrushina Yuliana Anatolevna
  • Smirnov Ivan Vitalevich
  • Aleshenko Natalya Leonidovna
  • Nikitin Aleksej Eduardovich
  • Chekhonin Vladimir Pavlovich
  • Gabibov Aleksandr Gabibovich
RU2784655C1
THE STRAIN OF HYBRID CULTURED HOMO SAPIENS/Mus MUSCULUS CELLS Hu-C6D7-RBD IS A PRODUCER OF HUMAN MONOCLONAL ANTIBODIES SPECIFIC TO THE RBD DOMAIN S OF THE SARS-CoV-2 VIRUS PROTEIN 2022
  • Romanenko Iana Olegovna
  • Silkina Marina Vladimirovna
  • Kartseva Alena Sergeevna
  • Marin Maksim Aleksandrovich
  • Konyshkova Daria Andreevna
  • Makarova Mariia Aleksandrovna
  • Shkuratova Mariia Andreevna
  • Shemiakin Igor Georgievich
  • Firstova Viktoriia Valerevna
RU2788359C1
SINGLE-DOMAIN NANO-ANTIBODIES AGAINST SPIKE PROTEIN OF SARS-CoV-2 VIRUS 2021
  • Chumakov Stepan Petrovich
  • Zhuchkov Vladislav Aleksandrovich
RU2794141C2
REGULATORY SEQUENCE TO INCREASE GENE EXPRESSION 2022
  • Nagornykh Maksim Olegovich
  • Reshetnikov Vasilii Vladimirovich
  • Terenin Ilia Mikhailovich
RU2804421C1

RU 2 730 250 C2

Authors

Shkurnikov Maksim Iurevich

Poloznikov Andrei Aleksandrovich

Dates

2020-08-19Published

2020-05-21Filed